NYSE:AVNS • US05350V1061
The current stock price of AVNS is 13.28 USD. Today AVNS is down by -3.7%. In the past month the price decreased by -0.79%. In the past year, price decreased by -9.51%.
ChartMill assigns a technical rating of 6 / 10 to AVNS. When comparing the yearly performance of all stocks, AVNS turns out to be only a medium performer in the overall market: it outperformed 57.39% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to AVNS. Both the profitability and the financial health of AVNS get a neutral evaluation. Nothing too spectacular is happening here.
On February 24, 2026 AVNS reported an EPS of 0.29 and a revenue of 180.90M. The company beat EPS expectations (14.64% surprise) and beat revenue expectations (1.52% surprise).
For the next year, analysts expect an EPS growth of 8.62% and a revenue growth 2.16% for AVNS
Over the last trailing twelve months AVNS reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS decreased by -25.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.79% | ||
| ROE | -9.37% | ||
| Debt/Equity | 0.12 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 29.55 | 57.868B | ||
| COO | COOPER COS INC/THE | 15.32 | 15.648B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.09 | 12.599B | ||
| SOLV | SOLVENTUM CORP | 10.58 | 12.28B | ||
| LNTH | LANTHEUS HOLDINGS INC | 13.81 | 4.93B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 17.31 | 4.368B | ||
| ICUI | ICU MEDICAL INC | 15.89 | 3.376B | ||
| HAE | HAEMONETICS CORP/MASS | 11.57 | 2.985B | ||
| XRAY | DENTSPLY SIRONA INC | 8.43 | 2.663B | ||
| NEOG | NEOGEN CORP | 30.16 | 2.325B | ||
| UFPT | UFP TECHNOLOGIES INC | 19.49 | 1.56B | ||
| STAA | STAAR SURGICAL CO | 129.23 | 923.672M | ||
| BVS | BIOVENTUS INC - A | 11.04 | 753.116M |
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,287 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
AVANOS MEDICAL INC
5405 Windward Parkway, Suite 100 South
Alpharetta GEORGIA 30004 US
CEO: Joseph F. Woody
Employees: 2227
Phone: 18444282667
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,287 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
The current stock price of AVNS is 13.28 USD. The price decreased by -3.7% in the last trading session.
AVNS does not pay a dividend.
AVNS has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
AVNS stock is listed on the New York Stock Exchange exchange.
The PE ratio for AVANOS MEDICAL INC (AVNS) is 14.13. This is based on the reported non-GAAP earnings per share of 0.94 and the current share price of 13.28 USD.
AVANOS MEDICAL INC (AVNS) currently has 2227 employees.